vTv Therapeutics Inc. (VTVT)

vTv Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	1	0	2.02	4.01	6.41	2.76
Revenue Growth (YoY)	5455.56%	-	-49.61%	-37.56%	132.05%	-77.77%
Gross Profit	1	0	2.02	4.01	6.41	2.76
Selling, General & Admin	12.4	11.91	12.2	12.34	7.25	8.54
Research & Development	12.3	13.6	12.36	13.32	11.02	15.12
Other Operating Expenses	-0.81	-0.57	-0.95	-1.61	0.27	-0.83
Operating Expenses	23.89	24.93	23.61	24.06	18.54	22.83
Operating Income	-22.89	-24.93	-21.59	-20.05	-12.12	-20.07
Interest Expense / Income	0.01	0.01	0.02	0.01	0.69	1.83
Other Expense / Income	-2.39	-4.69	-2.65	-7.19	-4.32	-8.95
Pretax Income	-20.52	-20.25	-18.96	-12.87	-8.5	-12.94
Income Tax	0.1	0	0.2	0.12	0	0.1
Net Income	-20.62	-20.25	-19.16	-12.99	-8.5	-13.04
Preferred Dividends	0	0	0	0	0	4.87
Net Income Common	-20.62	-20.25	-19.16	-12.99	-8.5	-17.91
Shares Outstanding (Basic)	3	3	3	2	2	1
Shares Change	15.14%	-	16.15%	21.87%	23.33%	47.01%
EPS (Basic)	-8.48	-9.71	-9.98	-8.29	-7.20	-23.60
EPS (Diluted)	-8.48	-9.71	-9.98	-8.29	-7.20	-23.60
Free Cash Flow	-21.25	-19.08	-16.04	-19.31	-18	-22.78
Free Cash Flow Per Share	-7.06	-7.30	-6.14	-8.58	-9.74	-15.21
Gross Margin	100.00%	-	100.00%	100.00%	100.00%	100.00%
Operating Margin	-2289.00%	-	-1070.07%	-500.70%	-188.99%	-725.94%
Profit Margin	-2061.60%	-	-949.65%	-324.27%	-132.51%	-648.08%
Free Cash Flow Margin	-2125.00%	-	-795.00%	-482.10%	-280.64%	-824.02%
EBITDA	-20.41	-20.15	-18.86	-12.77	-7.71	-11.08
EBITDA Margin	-2041.30%	-	-934.44%	-318.88%	-120.25%	-400.80%
Depreciation & Amortization	0.09	0.09	0.09	0.09	0.09	0.04
EBIT	-20.5	-20.24	-18.95	-12.86	-7.81	-11.12
EBIT Margin	-2050.30%	-	-939.00%	-321.10%	-121.72%	-402.21%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).